Latest & greatest articles for thyroid

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on thyroid or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on thyroid and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for thyroid

181. Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence. Full Text available with Trip Pro

Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.  To determine whether the use of imaging tests after primary treatment of differentiated thyroid cancer is associated with more treatment for recurrence and fewer deaths from the disease. Population based retrospective cohort study. Surveillance Epidemiology and End Results-Medicare database in the United States. 28 220 patients (...) diagnosed with differentiated thyroid cancer between 1998 and 2011. The study cohort was followed up to 2013, with a median follow-up of 69 months. Treatment for recurrence of differentiated thyroid cancer (additional neck surgery, additional radioactive iodine treatment, or radiotherapy), and deaths due to differentiated thyroid cancer. We conducted propensity score analyses to assess the relation between imaging (neck ultrasound, radioiodine scanning, or positron emission tomography (PET) scanning

2016 BMJ

182. LENVIMA (lenvatinib), protein kinase inhibitor - thyroid carcinoma

LENVIMA (lenvatinib), protein kinase inhibitor - thyroid carcinoma LENVIMA SUMMARY CT14510

2016 Haute Autorite de sante

183. Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules

Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules Ultr Ultrasound-guided percutaneous r asound-guided percutaneous radiofrequency adiofrequency ablation for benign th ablation for benign thyroid nodules yroid nodules Interventional procedures guidance Published: 22 June 2016 nice.org.uk/guidance/ipg562 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When (...) and efficacy of ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules is adequate to support the use of this procedure provided that standard arrangements are in place for clinical governance, consent and audit. © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 1 of 82 2 Indications and current treatments Indications and current treatments 2.1 Thyroid nodules may be cystic, colloid, hyperplastic

2016 National Institute for Health and Clinical Excellence - Interventional Procedures

184. Thyroid cancer. (Abstract)

Thyroid cancer. Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the standard treatment (surgery followed by either radioactive iodine or observation) is effective. Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally (...) treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers have prolonged progression-free survival, but these drugs are not curative and therefore are reserved for patients with progressive or symptomatic disease.Copyright © 2016 Elsevier Ltd. All rights reserved.

2016 Lancet

185. Neutron radiation therapy for advanced thyroid cancers Full Text available with Trip Pro

Neutron radiation therapy for advanced thyroid cancers The aim of this study was to review institutional outcomes for advanced thyroid cancers treated with fast neutron radiation therapy (FNRT) and photon radiation therapy (RT).In all, 62 consecutive patients were analyzed. Fifty-nine had stage IV disease. Twenty-three were treated with FNRT and 39 with photon RT. Median follow-up was 14 months. The primary endpoint was overall survival (OS).There was no significant difference in median OS

2016 Advances in radiation oncology

186. EFFICACY AND SAFETY OF MULTI-TARGETED KINASE INHIBITORS IN PROGRESSIVE, RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCERS: A META-ANALYSIS Full Text available with Trip Pro

EFFICACY AND SAFETY OF MULTI-TARGETED KINASE INHIBITORS IN PROGRESSIVE, RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCERS: A META-ANALYSIS EFFICACY AND SAFETY OF MULTI-TARGETED KINASE INHIBITORS IN PROGRESSIVE, RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCERS: A META-ANALYSIS | Journal of Cancer & Allied Specialties Search / / / Review Article Abstract Purpose: A meta-analysis was conducted to evaluate the impact of oral multitargeted kinase inhibitors (MTKIs) in radioactive-iodine (...) refractory locally advanced, recurrent/metastatic differentiated thyroid cancer (DTC) on disease control rate (DCR), progression-free survival (PFS) and overall survival (OS) rates. Materials and Methods: The PubMed/MEDLINE, CANCERLIT, EMBASE, Cochrane Library database and other search engines were searched to identify randomised controlled trials (RCTs) comparing MTKIs with placebo in locally advanced, recurrent/metastatic DTC. Pooled data were expressed as odds ratio (OR), with 95% con dence intervals

2016 Journal of Cancer & Allied Specialties

187. Can New Ultrasound Signs Help in Identifying Follicular Variant of Papillary Carcinoma of Thyroid? – A Pilot Study Full Text available with Trip Pro

Can New Ultrasound Signs Help in Identifying Follicular Variant of Papillary Carcinoma of Thyroid? – A Pilot Study To describe two new ultrasound signs for thyroid nodules - "nodule in nodule" and "hypoechoic internal septae" and assess their usefulness in differentiating follicular variant of papillary thyroid carcinoma (FVPTC) from benign thyroid nodules (BTN).Ultrasound findings of 210 patients with histopathologically proven FVPTC (68 nodules, M:F=13:47 with mean age of 39.5±11.9 years

2016 Ultrasound international open

188. Management of thyroid disease in pregnancy – Room for improvement in the first trimester Full Text available with Trip Pro

Management of thyroid disease in pregnancy – Room for improvement in the first trimester First-trimester care of maternal thyroid dysfunction has previously been shown to be poor. This study evaluates early management of thyroid dysfunction in pregnancy in Australia.Patients reviewed by the Obstetric Medicine team for thyroid dysfunction from 1 January 2012 to 30 June 2013 were included. Data were collected on gestation at referral from the patient's general practitioner to the antenatal (...) clinic, information provided in the referral letter, thyroid function tests and thyroid medications.Eighty-five women were included in the study. At the time of general practitioner referral to antenatal services, 19% of women with preexisting thyroid disease had no thyroid function tested. Forty-three percent had an abnormal thyroid-stimulating hormone defined as being outside the laboratory-specific pregnancy reference range if available, or outside the level of 0.1-2.5 mIu/L in the first trimester

2016 Obstetric medicine

189. Selumetinib with radioactive iodine therapy for differentiated thyroid cancer - first line

Selumetinib with radioactive iodine therapy for differentiated thyroid cancer - first line Selumetinib with radioactive iodine therapy for differentiated thyroid cancer – first line Selumetinib with radioactive iodine therapy for differentiated thyroid cancer – first line NIHR HSRIC Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSRIC. Selumetinib (...) with radioactive iodine therapy for differentiated thyroid cancer – first line. Birmingham: NIHR Horizon Scanning Research&Intelligence Centre. Horizon Scanning Review. 2016 Authors' conclusions There are four different types of thyroid cancer, and the most common is known as differentiated thyroid cancer. It is a type of cancer which usually develops very slowly, and can often be cured by surgery. However, in a small number of patients the cancer then returns and becomes difficult to treat. Radioactive iodine

2016 Health Technology Assessment (HTA) Database.

190. Thyroid Nodules. (Abstract)

Thyroid Nodules. 27028927 2016 03 31 2018 12 02 1533-4406 374 13 2016 03 31 The New England journal of medicine N. Engl. J. Med. Thyroid Nodules. 1294-5 10.1056/NEJMc1600493 Burman Kenneth D KD Wartofsky Leonard L eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Dec 10;373(24):2347-56 26650154 N Engl J Med. 2016 Mar 31;374(13):1294 27028928 N Engl J Med. 2016 Mar 31;374(13):1294 27028929 Female Humans Thyroid Nodule diagnosis 2016 3 31 6 0 2016 3 31 6 0

2016 NEJM

191. Thyroid Nodules. Full Text available with Trip Pro

Thyroid Nodules. 27028928 2016 03 31 2018 12 02 1533-4406 374 13 2016 03 31 The New England journal of medicine N. Engl. J. Med. Thyroid Nodules. 1294 10.1056/NEJMc1600493 Beano Abdallah M AM University of Jordan School of Medicine, Amman, Jordan baraaayman@gmail.com. Zmaili Mohammad A MA University of Jordan School of Medicine, Amman, Jordan baraaayman@gmail.com. Zayed Ayman A AA University of Jordan School of Medicine, Amman, Jordan baraaayman@gmail.com. eng Letter Comment United States N (...) Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Dec 10;373(24):2347-56 26650154 N Engl J Med. 2016 Mar 31;374(13):1294-5 27028927 Female Humans Thyroid Nodule diagnosis 2016 3 31 6 0 2016 3 31 6 0 2016 4 1 6 0 ppublish 27028928 10.1056/NEJMc1600493 10.1056/NEJMc1600493#SA1

2016 NEJM

192. Thyroid Nodules. Full Text available with Trip Pro

Thyroid Nodules. 27028929 2016 03 31 2018 12 02 1533-4406 374 13 2016 03 31 The New England journal of medicine N. Engl. J. Med. Thyroid Nodules. 1294 10.1056/NEJMc1600493 Seidenwurm David D Sutter Medical Group, Sacramento, CA breslaj@sutterhealth.org. Breslau Jonathan J Sutter Medical Group, Sacramento, CA breslaj@sutterhealth.org. eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Dec 10;373(24):2347-56 26650154 N Engl J Med. 2016 Mar 31;374(13):1294-5 (...) 27028927 Female Humans Thyroid Nodule diagnosis 2016 3 31 6 0 2016 3 31 6 0 2016 4 1 6 0 ppublish 27028929 10.1056/NEJMc1600493 10.1056/NEJMc1600493#SA2

2016 NEJM

194. Guidance on the reporting of thyroid cytology specimens

Guidance on the reporting of thyroid cytology specimens CEff 200116 1 V5 Final Guidance on the reporting of thyroid cytology specimens January 2016 Authors: Dr Paul Cross, Gateshead Health NHS Foundation Trust (Chair) Dr Ashish Chandra, Guys and St Thomas’s NHS Foundation Trust Dr Thomas Giles, Royal Liverpool and Broadgreen University Hospitals NHS Trust Dr Sarah Johnson, Newcastle upon Tyne Hospitals NHS Foundation Trust Dr Gabrijela Kocjan, University College London Hospitals NHS Foundation (...) Trust Dr David Poller, Portsmouth Hospitals NHS Trust Professor Tim Stephenson, Sheffield Teaching Hospitals NHS Foundation Trust Unique document number G089 Document name Guidance on the reporting of thyroid cytology specimens Version number 2 Produced by Dr P Cross (Chair), Dr A Chandra, Dr T Giles, Dr S Johnson, Dr G Kocjan, Dr D Poller and Professor T Stephenson. The authors are all consultant cellular pathologists, reporting thyroid histology and/or cytology, some of whom hold or have held

2016 Royal College of Pathologists

195. Guidance on the reporting of thyroid cytology specimens

Guidance on the reporting of thyroid cytology specimens CEff 200116 1 V5 Final Guidance on the reporting of thyroid cytology specimens January 2016 Authors: Dr Paul Cross, Gateshead Health NHS Foundation Trust (Chair) Dr Ashish Chandra, Guys and St Thomas’s NHS Foundation Trust Dr Thomas Giles, Royal Liverpool and Broadgreen University Hospitals NHS Trust Dr Sarah Johnson, Newcastle upon Tyne Hospitals NHS Foundation Trust Dr Gabrijela Kocjan, University College London Hospitals NHS Foundation (...) Trust Dr David Poller, Portsmouth Hospitals NHS Trust Professor Tim Stephenson, Sheffield Teaching Hospitals NHS Foundation Trust Unique document number G089 Document name Guidance on the reporting of thyroid cytology specimens Version number 2 Produced by Dr P Cross (Chair), Dr A Chandra, Dr T Giles, Dr S Johnson, Dr G Kocjan, Dr D Poller and Professor T Stephenson. The authors are all consultant cellular pathologists, reporting thyroid histology and/or cytology, some of whom hold or have held

2016 Royal College of Pathologists

196. AACE/ACE/AME Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules

AACE/ACE/AME Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules ENDOCRINE PRACTICE Vol 22 (Suppl 1) May 2016 1 AACE/ACE/AME Guidelines AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES – 2016 UPDATE APPENDIX Hossein Gharib, MD, MACP , MACE 1 , Co-Chair; Enrico Papini, MD, FACE 2 , Co-Chair (...) ; Jeffrey R. Garber, MD, FACP , FACE 3 ; Daniel S. Duick, MD, FACP , FACE 4 ; R. Mack Harrell, MD, FACP , FACE, ECNU 5 ; Laszlo Hegedüs, MD 6 ; Ralf Paschke, MD 7 ; Roberto Valcavi, MD, FACE 8 ; Paolo Vitti, MD 9 ; on behalf of the AACE/ACE/AME Task Force on Thyroid Nodules* American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE) and Associazione Medici Endocrinologi (AME) Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid

2016 American Association of Clinical Endocrinologists

197. Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies Full Text available with Trip Pro

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account (...) Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Practice Guideline Endokrynol Pol Actions . 2016;67(6):628-642. doi: 10.5603/EP.2016.0072. Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliation 1 Department of Paediatric Endocrinology and Rheumatology, Poznan University of Medical Sciences, Poznan, Poland

2016 Polish Clinical Guidelines

198. Thyroid Nodules. (Abstract)

Thyroid Nodules. 26650154 2016 01 12 2016 11 26 1533-4406 373 24 2015 Dec 10 The New England journal of medicine N. Engl. J. Med. CLINICAL PRACTICE. Thyroid Nodules. 2347-56 10.1056/NEJMcp1415786 Burman Kenneth D KD Wartofsky Leonard L eng Journal Article Review United States N Engl J Med 0255562 0028-4793 9002-71-5 Thyrotropin AIM IM N Engl J Med. 2016 Mar 31;374(13):1294-5 27028927 N Engl J Med. 2016 Mar 31;374(13):1294 27028928 N Engl J Med. 2016 Mar 31;374(13):1294 27028929 Adult Algorithms (...) Biopsy, Fine-Needle Female Humans Practice Guidelines as Topic Thyroid Nodule diagnosis diagnostic imaging pathology therapy Thyroidectomy Thyrotropin blood Ultrasonography 2015 12 10 6 0 2015 12 10 6 0 2016 1 13 6 0 ppublish 26650154 10.1056/NEJMcp1415786

2015 NEJM

199. South Korea's Thyroid-Cancer "Epidemic" - Turning the Tide. (Abstract)

South Korea's Thyroid-Cancer "Epidemic" - Turning the Tide. 26650173 2016 01 12 2019 02 21 1533-4406 373 24 2015 Dec 10 The New England journal of medicine N. Engl. J. Med. South Korea's Thyroid-Cancer "Epidemic"--Turning the Tide. 2389-90 10.1056/NEJMc1507622 Ahn Hyeong Sik HS Korea University, Seoul, South Korea ahnhs@korea.ac.kr. Welch H Gilbert HG eng Letter United States N Engl J Med 0255562 0028-4793 AIM IM Carcinoma diagnostic imaging epidemiology Carcinoma, Papillary Epidemics (...) Guidelines as Topic Humans Mass Screening economics statistics & numerical data Medical Overuse trends Republic of Korea epidemiology Thyroid Cancer, Papillary Thyroid Neoplasms diagnostic imaging epidemiology surgery Ultrasonography 2015 12 10 6 0 2015 12 10 6 0 2016 1 13 6 0 ppublish 26650173 10.1056/NEJMc1507622

2015 NEJM

200. Sudden thyroid death. A systematic review Full Text available with Trip Pro

Sudden thyroid death. A systematic review Sudden thyroid death. A systematic review . Register & Log-in Rom J Leg Med23(4)233-242(2015) © Romanian Society of Legal Medicine Sudden thyroid death. A systematic review S. Hostiuc, L. Luca, D. B. Iliescu, M. I. Dascălu, E. Drima, I. Rențea, A. Moldoveanu, M. Ceaușu, D. Pirici Abstract: Sudden death due to thyroid disorders is a rare occurrence in forensic practice. Marked changes of thyroid plasma hormones in short periods of time are known (...) to be life threatening, but they are usually identifiable in patients with known thyroid disorders, and therefore do not comply with the definition of sudden death. In order to properly identify published sudden thyroid death cases we performed an extensive search on Web of Science. We found 31 articles containing case presentations of possible sudden thyroid deaths, from which were identified a total number of 42 cases. There are three main thyroid pathologies associated with sudden unexpected death

2015 Romanian Journal of Legal Medicine